Home › Stem Cell Cures

Stem Cell Cures

News Story
5/3/2010
Posted by Consumer Watchdog
The Wisconsin Alumni Research Foundation has suffered a blow in its effort to protect a key patent for embryonic stem cell technology. The U.S. Patent and Trademark Office last week reversed an earlier decision in which it rejected an appeal on one of three basic human embryonic stem cell patents held by the foundation, known as WARF. The patent...
News Release
5/3/2010
Posted by Consumer Watchdog
WASHINGTON, D.C. -- In what two consumer groups today praised as a victory for open scientific inquiry, the U.S. Patent and Trademark Office has rejected a controversial patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF). “This is a major victory for unfettered scientific research that could lead to...
News Story
5/3/2010
Posted by Consumer Watchdog
The U.S. Patent and Trademark Office's Board of Appeals and Interference has reversed an earlier decision from the Patent Office's re-examination division that upheld the claims of one of the stem cell lines held by the Wisconsin Alumni Research Foundation. The patent covers one of the three key stem cell lines that were challenged through re-...
News Story
5/3/2010
Posted by Consumer Watchdog
MADISON, Wis. -- Consumer groups challenging a key patent covering embryonic stem cell research pioneered at the University of Wisconsin-Madison have won an appeal overturning an earlier rejection of their claims. The U.S. Patent and Trademark Office ruled Wednesday in favor of the two consumer groups that challenged one of the patents held by the...
News Story
5/3/2010
Posted by Consumer Watchdog
Local Researchers Applaud Decision A key patent on how to grow human embryonic stem cells has been rejected by a federal agency, the latest twist in a complicated, years-long case. Researchers in San Diego's large biotech community say the decision could make it easier to turn laboratory discoveries into disease treatments. Human embryonic stem...
News Story
3/18/2010
Posted by Consumer Watchdog
Lawmakers -- again -- are questioning the operations and culture of the state's stem cell program, which was created by voters nearly six years ago in Proposition 71 and has placed California at the forefront of stem-cell research and development. But the issue isn't so much the scientific savvy of the California Institute for Regenerative...
News Story
2/18/2010
Posted by Consumer Watchdog
Ten years ago, scientists discovered stem cells in the dental pulp of human teeth. Despite the fact that there are still no FDA-approved therapies using these cells, companies are emerging that charge consumers up to $1,600 to extract and store them. But is there enough scientific evidence to support this type of cellular banking? "We simply...
Blog Post
2/11/2010
Posted by Consumer Watchdog
I got a phone call this week from Bob Klein, chairman of the California stem cell agency and its board's attorney, James Harrison. They wanted to make sure I understood that there is no fixed, 10-year life span for the California Institute of Regenerative Medicine. There is no sunset provision. I told them I knew that, but agreed many people seem...
News Story
12/14/2009
Posted by Consumer Watchdog
There is one consolation for Mayor Gavin Newsom now that he's dropped out of the governor's race - he won't have to take a $72,477-a-year pay cut. Newsom, who earns $246,464 as mayor of San Francisco, would have seen his pay drop to $173,987 if he had won the governor's race, as a result of the salary cuts imposed on state elected officers last...
News Story
12/12/2009
Posted by Consumer Watchdog
The state's stem cell institute this week tripled the salary of one of its vice chairmen, former state Democratic Party chief Art Torres. Torres previously received $75,000 a year to work half time as vice chairman. The board of the California Institute for Regenerative Medicine voted Thursday to bump that up to $225,000 for 80 percent of his time...